Research News for July 27, 2022
advertisement
- Potential target for Type 1 diabetes treatment
- Gut Microbe Peptide Implicated in Triggering Type 1 Diabetes
- A gut microbial peptide and molecular mimicry in the pathogenesis of type 1 diabetes
- A user preference analysis of commercial breath ketone sensors to inform the development of portable breath ketone sensors for diabetes management in young people
- Development of the Extended Infusion Set and Its Mechanism of Action
- The Contribution of Neutrophils and NETs to the Development of Type 1 Diabetes (Full text HTML, PDF)
- Systematic Review of Safety and Efficacy of IL-1-Targeted Biologics in Treating Immune-Mediated Disorders (Full text HTML, PDF)
- Ethics of Early Clinical Trials of Bio-Artificial Organs (Full text HTML, PDF)
- Does the Gut Microbiome Play a Role in Obesity in Type 1 Diabetes? Unanswered Questions and Review of the Literature (Full text HTML, PDF)
- Targeting hIAPP fibrillation: A new paradigm to prevent β-cell death?
- Antigen-specific immunotherapies in type 1 diabetes (Full text HTML, PDF)
- Engineered immunomodulatory accessory cells improve experimental allogeneic islet transplantation without immunosuppression (Full text HTML)
- Detection of enterovirus RNA in peripheral blood mononuclear cells correlates with the presence of the predisposing allele of the type 1 diabetes risk gene IFIH1 and with disease stage
- Consortium-based approach to receiving an EMA qualification opinion on the use of islet autoantibodies as enrichment biomarkers in type 1 diabetes clinical studies
- Impact of Geographical Location on the Gut Microbiota Profile in Egyptian Children with Type 1 Diabetes Mellitus: A Pilot Study (Full text HTML, PDF)
- The challenge of HLA donor specific antibodies in the management of pancreatic islet transplantation: an illustrative case-series (Full text HTML, PDF)
- Inhibition of pancreatic EZH2 restores progenitor insulin in T1D donor (Full text HTML, PDF)
